Ask AI
Pharmacologic View of Tardive Dyskinesia

CE / CME

A Pharmacologic View of Tardive Dyskinesia: Pathology and Treatment

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Nurse Practitioners/Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: December 27, 2024

Expiration: December 26, 2025

Pretest

Progress
1 2
Course Completed
1.

Of the following risk factors for developing TD, which is of particular relevance in older patients?

2.

Which of the following must be discontinued when using a VMAT2 inhibitor to treat TD?

3.

Which statement is true as supported by published data on VMAT2 inhibitors specific to older adults with TD?